These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 12052284)
41. Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results. Markus HS; Levi C; King A; Madigan J; Norris J; JAMA Neurol; 2019 Jun; 76(6):657-664. PubMed ID: 30801621 [TBL] [Abstract][Full Text] [Related]
42. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation. Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607 [TBL] [Abstract][Full Text] [Related]
48. Clinical implication of antiembolic trials in atrial fibrillation and role of transesophageal echocardiography in atrial fibrillation. Jagasia DH; Williams B; Ezekowitz MD Curr Opin Cardiol; 2000 Jan; 15(1):58-63. PubMed ID: 10666662 [TBL] [Abstract][Full Text] [Related]
49. Antiplatelet versus anticoagulant therapies in advanced age: an unfinished task. García-Honrubia A; Roldán V; Climent V; Sogorb F; Marín F Int J Cardiol; 2006 Jun; 110(2):271-2. PubMed ID: 16343666 [TBL] [Abstract][Full Text] [Related]
50. Aspirin and warfarin equally good for stroke patients. Gottlieb S BMJ; 2001 Nov; 323(7323):1204. PubMed ID: 11719405 [No Abstract] [Full Text] [Related]
51. Warfarin compared with aspirin for older Chinese patients with stable coronary heart diseases and atrial fibrillation complications. Liu X; Huang H; Yu J; Cao G; Feng L; Xu Q; Zhang S; Zhou M; Li Y Int J Clin Pharmacol Ther; 2014 Jun; 52(6):454-9. PubMed ID: 24755126 [TBL] [Abstract][Full Text] [Related]
53. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1. Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521 [TBL] [Abstract][Full Text] [Related]
54. [Atrial fibrillation and thromboembolic events prevention. State of the art]. Matteoli S; Trappolini M; Chillotti FM Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381 [TBL] [Abstract][Full Text] [Related]
55. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Homma S; Sacco RL; Di Tullio MR; Sciacca RR; Mohr JP; Circulation; 2002 Jun; 105(22):2625-31. PubMed ID: 12045168 [TBL] [Abstract][Full Text] [Related]
56. Warfarin or aspirin for recurrent ischemic stroke. Butera G; Chessa M; Carminati M N Engl J Med; 2002 Apr; 346(15):1169-71. PubMed ID: 11951856 [No Abstract] [Full Text] [Related]
57. Anticoagulants for prevention of ischemic stroke: current concepts. Mohr JP Adv Neurol; 2003; 92():263-70. PubMed ID: 12760192 [No Abstract] [Full Text] [Related]
58. Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation. Cleland JG; Kaye GC BMJ; 2001 Jul; 323(7306):233; author reply 235-6. PubMed ID: 11496885 [No Abstract] [Full Text] [Related]
59. Anticoagulation for atrial fibrillation in the elderly. Halperin JL Am J Geriatr Cardiol; 2005; 14(2):81-6. PubMed ID: 15785149 [TBL] [Abstract][Full Text] [Related]
60. Incidence of new thromboembolic stroke in persons 62 years and older with chronic atrial fibrillation treated with warfarin versus aspirin. Aronow WS; Ahn C; Kronzon I; Gutstein H J Am Geriatr Soc; 1999 Mar; 47(3):366-8. PubMed ID: 10078902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]